Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI

BACKGROUND: We aimed to explore the correlation between blood lipids (high density lipoprotein cholesterol [HDL‐C] and apolipoprotein A1 [ApoA1]) and epidermal growth factor receptor (EGFR) T790M mutation, as well as its predictive role in clinical efficacy and progression‐free survial (PFS) in adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Juan, Bai, Ying, Liu, Mei, Jiao, Tong, Chen, Yang, Yuan, Bo, Liu, Boxuan, Zeng, Lizhong, Ming, Zongjuan, Li, Wei, Sun, Ruiying, Yang, Xia, Yang, Shuanying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013640/
https://www.ncbi.nlm.nih.gov/pubmed/35274478
http://dx.doi.org/10.1111/1759-7714.14367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013640/
https://www.ncbi.nlm.nih.gov/pubmed/35274478
http://dx.doi.org/10.1111/1759-7714.14367

Ejemplares similares